Catalent (CTLT) Tops Q2 EPS by 8c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Catalent, Inc. Reports Second Quarter Fiscal 2019 Results
February 5, 2019 7:30 AM ESTQ2'19 revenue of $623.0 million increased 3% as-reported, or 5% in constant currency, from the prior-year period. Q2'19 YTD revenue of $1,174.8 million increased 2% as-reported, or 4% in constant currency, from the prior-year period. Double-digit organic segment EBITDA growth within Biologics and Specialty Drug Delivery and Clinical Supply Services segments; Juniper acquisition continues to out-perform internal expectations. FY'19 financial guidance reaffirmed.
SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE: CTLT), the... More
